Search
Artelo Biosciences Inc
ARTLAdd to Watchlist
1.110USD
+0.010+0.91%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
747.04KMarket Cap
LossP/E TTM
Risk Assessment
Currency: USD Updated: 2026-07-02The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Biotechnology & Medical Research domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. No risk assessment score is currently available for Artelo Biosciences Inc. The Biotechnology & Medical Research industry's average is 3.36. The company's beta value is -0.09. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.
Beta vs S&P 500 index
-0.09
VaR
+8.16%
240-Day Maximum Drawdown
+97.55%
240-Day Volatility
+216.75%
Return
Best Daily Return
60 days
+43.70%
120 days
+230.41%
5 years
+230.41%
Worst Daily Return
60 days
-21.37%
120 days
-34.23%
5 years
-50.34%
Sharpe Ratio
60 days
-4.89
120 days
+0.15
5 years
-0.20
Risk Assessment
Maximum Drawdown
240 days
+97.55%
3 years
+98.71%
5 years
+99.65%
Return-to-Drawdown Ratio
240 days
-1.00
3 years
-0.33
5 years
-0.20
Skewness
240 days
+9.57
3 years
+11.46
5 years
+12.51
Volatility
Realised Volatility
240 days
+216.75%
5 years
+151.23%
Standardised True Range
240 days
+105.79%
5 years
+374.27%
Downside Risk-Adjusted Return
120 days
+57.06%
240 days
+57.06%
Maximum Daily Upside Volatility
60 days
+146.32%
Maximum Daily Downside Volatility
60 days
+126.28%
Liquidity
Average Turnover Rate
60 days
+262.78%
120 days
+362.50%
5 years
--
Turnover Deviation
20 days
-63.82%
60 days
+130.94%
120 days
+218.58%